HST Global Inc. Net Current Asset Value

Net Current Asset Value of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Current Asset Value growth rates and interactive chart.


Highlights and Quick Summary

  • Net Current Asset Value for the quarter ending June 29, 2020 was $-82.3 Thousand (a 114.88% increase compared to previous quarter)
  • Year-over-year quarterly Net Current Asset Value decreased by -472.4%
  • Annual Net Current Asset Value for 2019 was $-3.4 Thousand (a -99.9% decrease from previous year)
  • Annual Net Current Asset Value for 2018 was $-3.37 Million (a 5.58% increase from previous year)
  • Annual Net Current Asset Value for 2017 was $-3.19 Million (a 5.45% increase from previous year)
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Current Asset Value of HST Global Inc.

Most recent Net Current Asset Valueof HSTC including historical data for past 10 years.

Interactive Chart of Net Current Asset Value of HST Global Inc.

HST Global Inc. Net Current Asset Value for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-0.08 $-0.04
2019 $-0.0 $0.02 $-0.96 $-3.42 $-0.0
2018 $-3.37 $-3.33 $-3.28 $-3.24 $-3.37
2017 $-3.19 $-3.15 $-3.13 $-3.09 $-3.19
2016 $-3.03 $-2.98 $-2.94 $-2.9 $-3.03
2015 $-2.85 $-2.81 $-2.77 $-2.72 $-2.85
2014 $-2.66 $-2.61 $-2.57 $-2.52 $-2.66
2013 $-2.47 $-2.43 $-2.39 $-2.32 $-2.47
2012 $-2.28 $-2.19 $-2.1 $-1.99 $-2.28
2011 $-1.91 $-1.79 $-1.71 $0.0 $-1.91
2010 $-1.84 $-1.68 $-1.53 $-1.32 $-1.85
2009 $-1.32 $-1.33

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.